|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:FDA
1977
|
|
gptkbp:ATCCode
|
M03BX08
|
|
gptkbp:brand
|
gptkb:cyclobenzaprine
|
|
gptkbp:chemicalFormula
|
C20H21N
|
|
gptkbp:contraindication
|
congestive heart failure
MAOI use
heart block
hyperthyroidism
|
|
gptkbp:discontinued
|
gptkb:Australia
gptkb:Canada
|
|
gptkbp:drugClass
|
muscle relaxant
|
|
gptkbp:eliminatedIn
|
urine
feces
|
|
gptkbp:form
|
gptkb:tablet
extended-release capsule
|
|
gptkbp:genericName
|
gptkb:cyclobenzaprine
|
|
gptkbp:halfLife
|
18 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Flexeril
|
|
gptkbp:interactsWith
|
gptkb:beer
gptkb:tricyclic_antidepressants
gptkb:MAO_inhibitors
gptkb:CNS_depressants
|
|
gptkbp:legalStatus
|
Rx-only (US)
|
|
gptkbp:manufacturer
|
gptkb:Merck
|
|
gptkbp:marketedIn
|
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
central nervous system depressant
reduces tonic somatic motor activity
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
275.39 g/mol
|
|
gptkbp:notRecommendedFor
|
elderly
children under 15
|
|
gptkbp:overdoseSymptoms
|
cardiac arrest
seizures
drowsiness
tachycardia
hallucinations
agitation
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
drowsiness
dry mouth
|
|
gptkbp:synonym
|
cyclobenzaprine hydrochloride
|
|
gptkbp:usedFor
|
muscle spasms
|
|
gptkbp:bfsParent
|
gptkb:cyclobenzaprine
|
|
gptkbp:bfsLayer
|
8
|